Education
About Us
Working with TipRanks
Follow Us
LSL Pharma Group Inc (TSE:LSL)
:LSL
LSL Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.29 - C$0.50
Previous CloseN/A
VolumeN/A
Average Volume (3M)42.95K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)14.04M
Price to Earnings (P/E)13.3
Beta0.71
Next Earnings
Aug 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding115,532,680
10 Day Avg. Volume44,176
30 Day Avg. Volume42,950
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
LSL Pharma Group Inc News
PremiumCompany Announcements
LSL Pharma Group Announces Key Decisions from Annual Shareholder MeetingPremiumCompany Announcements
LSL Pharma Group Secures $17.5 Million in New Financing
PremiumCompany Announcements
LSL Pharma Group Achieves Record Q1 Revenues and Expands Eye-Care Portfolio
PremiumCompany Announcements
LSL Pharma Group Reports Strong Financial Turnaround in FY-24
PremiumCompany Announcements
LSL Pharma Group to Participate in 2025 Healthcare Investor Conference
PremiumCompany Announcements
LSL Pharma Group Expands Ophthalmic Portfolio with New AgreementsOptions Prices
Currently, No data available
---
Ownership Overview
0.24% Insiders
―
Mutual Funds
― Other Institutional Investors
99.76% Public Companies and
Individual Investors
LSL FAQ
What was LSL Pharma Group Inc’s price range in the past 12 months?
LSL Pharma Group Inc lowest stock price was C$0.29 and its highest was C$0.50 in the past 12 months.
What is LSL Pharma Group Inc’s market cap?
Currently, no data Available
When is LSL Pharma Group Inc’s upcoming earnings report date?
LSL Pharma Group Inc’s upcoming earnings report date is Aug 27, 2025 which is in 60 days.
How were LSL Pharma Group Inc’s earnings last quarter?
Currently, no data Available
Is LSL Pharma Group Inc overvalued?
According to Wall Street analysts LSL Pharma Group Inc’s price is currently Overvalued.
Does LSL Pharma Group Inc pay dividends?
LSL Pharma Group Inc does not currently pay dividends.
What is LSL Pharma Group Inc’s EPS estimate?
LSL Pharma Group Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LSL Pharma Group Inc have?
LSL Pharma Group Inc has 115,532,680 shares outstanding.
What happened to LSL Pharma Group Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of LSL Pharma Group Inc?
Currently, no hedge funds are holding shares in TSE:LSL
Company Description
LSL Pharma Group Inc
LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.
Technical Analysis
Genix Pharmaceuticals
―
Love Pharma Inc
―
Mydecine Innovations Group
―
Lumiera Health Inc
―
NAVCO Pharmaceuticals Inc
―